USFDA approves DRL's Azacitidine for injection

 Dr Reddy's Laboratories today announced that the US Food and Drug Administration has approved Azacitidine for injection 100 mg/vial, a bioequivalent generic version of Vidaza (azacitidine for injection).

Azacitidine is used to treat certain types of bone marrow cancers and blood cell disorders. 

The launch of product in the market is planned in the near-term.

Azacitidine for injection 100 mg/vial is available in single use-vials, it said. 

ps- this is only for information, always consult you physician before having any particular food/ medication/exercise/other remedies.

ps- those interested in recipes are free to view my blog-

http://gseasyrecipes.blogspot.com/

for info about knee replacement, you can view my blog-

http://Knee replacement-stick club.blogspot.com/

for crochet designs

http://My Crochet Creations.blogspot.com